glp-1 or semaglutide Comparing Ozempic, Wegovy and Other Drugs Novo Nordisk Drops Hims &
Description
After achieving their weight-loss goals, a lower maintenance dose may help support appetite control and long-term weight stability

These trials will also provide much-needed prospective data on the safety of GLP-1RA in patients with IBD

Heres what I want you to know: we do not have strong clinical trial evidence proving that very small doses deliver the big claims being marketed

What to record: Number of bathroom visits per day (daytime and nighttime separately) Approximate volume (small, moderate, large) Any pain, burning, urgency, or incontinence Urine color throughout the day Total daily fluid intake (type and amount) Current tirzepatide dose and how long at this dose All other medications and supplements Blood sugar readings if applicable This data allows your provider to quickly distinguish between harmless metabolic adjustment and something requiring investigation
